NCT02680561View on ClinicalTrials.gov

A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions

Asthma

Interventions

DRUG

Fluticasone Propionate MDPI

DRUG

Fluticasone Propionate/Salmeterol MDPI

DRUG

Fluticasone propionate/salmeterol

Trial Locations (3)

Unknown

Teva Investigational Site 13679, Huntington Beach

Teva Investigational Site 13678, Raleigh

Teva Investigational Site 13677, San Antonio

All Listed Sponsors

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT02680561 - A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma | Biotech Hunter | Biotech Hunter